Coriolis Pharma Announces Plans To Invest $10 Million Into New R&D Laboratory In North Carolina
Coriolis Pharma, a leading provider of formulation research and development services for biologics, today announced plans to invest $10 million in the establishment of a state-of-the-art research laboratory and to create 50 jobs in Morrisville, North Carolina.
Founded in Martinsried, Germany, Coriolis Pharma is the premier partner for drug product development, analytical, and manufacturing services, supporting a wide range of biological therapeutic modalities. Coriolis designs and executes platform-based and custom solutions to accelerate and safeguard its clients’ programs from early development through commercialization.
“The investment in a new lab in Morrisville is a significant milestone for Coriolis. With our future presence in North Carolina, we will be able to serve our North American clients even better, offering our core services quickly and efficiently on site,” said Silvia Steyrer-Gruber, Chief Executive Officer of Coriolis Pharma. “The decisive factor in our choice of location was the strong scientific fit with the North Carolina ecosystem, a global biotechnology center of excellence. The innovative environment, proximity to numerous life science companies and excellent infrastructure around Morrisville, reinforced our decision”.
Coriolis Pharma has grown with strategic foresight since its founding in 2008, consistently staying ahead of industry trends and driving scientific advances. In 2024, Coriolis established a U.S. business entity, expanding its global footprint to better serve North American clients. This move also marked the launch of Coriolis’ accelerator platform services, designed to fast-track products from early-stage research to phase I clinical readiness.
“We warmly welcome Coriolis to Wake County – the premiere destination for life sciences companies from across the country and around the world,” said Wake County Board of Commissioners Chair Susan Evans. “We’re like a magnet that attracts the most innovative biotech businesses, because we have the talent and the resources they need to succeed.”
Coriolis selected the Town of Morrisville for its first U.S. facility and U.S. headquarters to offer its core services on-site, including particle identification in the initial phase, followed by formulation development and lyophilization services. Morrisville’s strategic location, talented workforce, high quality of life and business friendly environment make it an optimal location for investment.
“We are proud to welcome Coriolis Pharma and their new U.S. headquarters to Morrisville’s Spark Campus,” said T.J. Cawley, Mayor of the Town of Morrisville. “This milestone reflects years of strategic work to attract life sciences investment to our town, including opening hundreds of acres to innovation and updating our regulations to support companies developing life-changing and life-saving treatments. Coriolis joins a thriving ecosystem of global biotech leaders here in Morrisville, the emerging nexus of life sciences in North Carolina—the best state for business and a community committed to building a healthier, happier world. We look forward to being a strong partner in their continued success.”
“Morrisville is incredibly proud that Coriolis, a leader in life sciences, chose Morrisville for its first U.S. facility," said Tiffany McNeill, Economic Development Director for the Town of Morrisville. "This investment aligns with our strategic efforts to attract innovative companies, underscoring our prime strategic location and highly talented workforce. We've cultivated an environment where advanced operations like theirs can thrive, reinforcing Morrisville as a premier destination for businesses.”
Home to more than 650 operations, the life science industry in the Triangle region is booming. From CROs to CDMOs and cell & gene therapy, and startups to global leaders, companies flourish in this global life science hub. Wake County brings together research, talent and community to scale the industry and move ideas to market.
Coriolis Pharma offers high-quality services for liquid and lyophilized biopharmaceuticals. Its outstanding scientific expertise across many different modalities, its deep knowledge in formulation development, and a wide range of innovative analytical methods make Coriolis Pharma a valued partner in the pharmaceutical and biotech industry.
Numerous partners collaborated to make this announcement a reality. Partners on this project include:
- The Economic Development Partnership of North Carolina
- North Carolina Community College System
- NC Commerce Division of Workforce Solutions
- The North Carolina Biotechnology Center
- Wake Technical Community College
- Capital Area Workforce Development Board
- The Town of Morrisville
- Wake County Government
- Wake County Economic Development, a program of the Greater Raleigh Chamber